New diabetes clinical trial: Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Published on: October 28, 2022 at 11:00AM
Conditions:   Type 2 Diabetes Mellitus in Remission;   Metabolic Associated Fatty Liver Disease
Intervention:   Procedure: Ultrasound attenuation parameter measurement, fasting blood glucose and fasting insulin determination
Sponsors:   Wuxi Hisky Medical Technology Co Ltd;   Zhongda Hospital, Medical School, Southeast University;   Suzhou Municipal Hospital;   Suzhou Fifth People's Hospital;   Xuzhou Mining Group General Hospital;   Nantong First People's Hospital;   Changzhou Second People's Hospital;   Huaian Second People's Hospital;   Huaian Hospital;   Taizhou Jiangyan Traditional Chinese Medicine Hospital;   Yangzhou Jiangdu People's Hospital;   Huaian Xuyi County People's Hospital
Recruiting
https://ift.tt/lER5Kjd